Evidence map›Paper›PMID 42707714›Full record

ReviewJournal of inflammation research2026

To Die or Not to Die: How Sublethal Damage Rewires Cell Fate and Implications for Sepsis.

Zihan Hu, Xing Zhou, Qin Sun, Lianlian Jiang, Mengfan Wu, Jianfeng Xie, Yi Yang, Fei Peng

Abstract readReview
In one paragraph

Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zihan Hu *Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.ORCID 0009-0008-4096-4775
Xing Zhou *Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
Qin SunJiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
Lianlian JiangJiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
Mengfan WuJiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
Jianfeng XieJiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
Yi Yang *Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
Fei Peng *Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lytic cell death has long been regarded as an irreversible process culminating in plasma membrane rupture. However, accumulating evidence indicates that the activation of lytic pathways does not invariably result in cell lysis. Instead, cells can undergo sublethal membrane damage, a state in which membrane injury is limited, allowing cells to remain viable while triggering persistent inflammation, barrier dysfunction and other functional alterations. This potentially reversible state may provide a therapeutic window in which limiting membrane rupture or enhancing membrane repair could preserve viable but compromised cells. This review focuses on the three major forms of lytic cell death: pyroptosis, necroptosis, and ferroptosis. We summarize the canonical molecular mechanisms, processes of membrane injury, regulatory pathways, and consequences of sublethal membrane damage. Furthermore, we discuss the shared features and biological impacts of sublethal membrane damage. Given the heterogeneous responses in sepsis, sublethal membrane damage may provide a relevant framework for understanding sepsis pathophysiology. A deeper understanding of this intermediate state may offer novel strategies for sepsis that aim not only to prevent complete cell lysis but also to modulate the function of viable but compromised cells.

Indexed as

ferroptosislytic cell deathnecroptosispyroptosissepsissublethal membrane damage

Identifiers

PMID42707714
PMCPMC13549322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.